Jupiter Wellness, Inc. (JUPW) Stock Plummets Following Pricing of Underwritten Public Offering
Jupiter Wellness, Inc. (JUPW) stock prices were down 15.45% as of the market closing on July 21st, 2021, bringing the price per share down to USD$2.79 at the end of the trading day. Subsequent premarket fluctuations saw the stock plummet by another 21.15%, bringing it down to USD$2.20. >> 7 Top Picks for the Post-Pandemic […]
MannKind Corp. (MNKD) Stock Surges Following Expanded Medicaid Inclusion
MannKind Corp. (MNKD) stock prices were up by a marginal 0.64% as of the market closing on June 25th, 2021, bringing the price per share up to USD$4.74 at the end of the trading day. Subsequent premarket fluctuations saw the stock rise by 10.13%, bringing it up to USD$5.22. >> 7 Top Picks for the […]
Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial
Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share up to USD$1.48 early on in the trading day. Solid Liquidity Position The company reported a stellar liquidity position at the end of the fourth quarter of fiscal 2021, with cash […]
Solid Biosciences Inc. (SLDB) Stock Skyrockets as Latest Target of Reddit-Driven Short Squeeze of Meme Stocks
Solid Biosciences Inc. (SLDB) stock prices were up by 2.91% as of the market closing on June 8th, 2021, bringing the price per share up to USD$4.06 at the end of the trading day. Subsequent current market fluctuations have seen the stock soar by 3.20%, bringing it up to USD$4.19. Meme Stock Phenomenon In the […]
Clovis Oncology, Inc. (CLVS) Stock Soars Amid Continuing Meme Stock Phenomenon
Clovis Oncology, Inc. (CLVS) stock prices were up by 4.77% as of the market closing on June 8th, 2021, bringing the price per share up to USD$5.71 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 18.21% bringing it up to USD$6.75. Get the hottest stocks […]
Aethlon Medical, Inc. (AEMD) Stock Skyrockets Following Success of Hemopurifier Treatment in Covid-19 Patient
Aethlon Medical, Inc. (AEMD) stock prices were up by a marginal 0.45% as of the market closing on June 8th, 2021, bringing the price per share up to USD$2.21 at the end of the trading day. After-hours trading saw the stock skyrocket by an astounding 92.31%, bringing it up to USDS$4.25. EUA for Hemopurifier The […]
Vaxart, Inc. (VXRT) Stock Trending Higher Following Enrollment of First Patient in Norovirus Clinical Trial
Vaxart, Inc. (VXRT) stock prices were up by 6.84% as of the market closing on June 7th, 2021, bringing the price per share up to USD$7.34 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 4.22%, bringing it up to USD$7.65. Get the hottest stocks to trade every […]
PDS Biotechnology Corp. (PDSB) Stock Rallies Following Inclusion in Russell Microcap Index
PDS Biotechnology Corp. (PDSB) stock prices were down by a concerning 26.45% as of the market closing on June 7th, 2021, bringing the price per share down to USD$9.40 at the end of the trading day. Subsequent pre-market fluctuations saw the stock rise by 8.51%, bringing it up to USD$10.20. Inclusion in Russell Microcap Index […]
Clover Health Investments, Corp. (CLOV) Stock Soars Thanks to Meme Stock Status and Reddit Investors
Clover Health Investments, Corp. (CLOV) stock prices soared by a significant 32.44% as of the market closing on June 7th, 2021, bringing the price per share up to USD$11.92 at the end of the trading day. After-hours trading saw the stock climb by another 8.22%, bringing it up to USD$12.90. Recent Woes This comes in […]
Adamis Pharmaceuticals Corp. (ADMP) Stock Surges Following Promising News of TEMPOL as Potential Covid-19 Treatment
AdamisPharmaceuticals Corp. (ADMP) stock prices were up by a significant 17.84% shortly after market trading commenced on June 7th, 2021, bringing the price per share up to USD$1.1784 early on in the trading day. TEMPOL The company announced on June 7th, 2021 that the National Institute of Health (NIH) had identified the company’s proprietary experimental […]
CoherusBioSciences, Inc. (CHRS) Stock on the Rise Following Success of JUPITER-02 Pivotal Study
CoherusBioSciences, Inc. (CHRS) stock prices were up by 3.53% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$13.50 early on in the trading day. JUPITER-02 Results The company recently announced the successful results from its pivotal study, JUPITER-02, which was a randomized, double-blind, placebo-controlled Phase 3 clinical […]
Leap Therapeutics, Inc. (LPTX) Stock Poised to Rise Following Surge in Trading Volume
Leap Therapeutics, Inc. (LPTX) stock prices were own by a marginal 0.62% as of the market closing on June 3rd, 2021, bringing the price per share down to USD$1.61. After-hours trading saw the stock surge by 14.91%, bringing it up to USD$1.85. Net Loss Reports Net loss reported for the first quarter of the fiscal […]
Teladoc Health, Inc. (TDOC) Stock Continues to Prosper as Telehealth Sector Booms During Pandemic
Teladoc Health, Inc. (TDOC) stock prices were up by 0.25% as of the market closing on June 2nd, 2021, bringing the price per share up to USD$152.74 at the end of the trading day. Subsequent pre-market fluctuations saw the stock creep up by another 0.89%, bringing it up to USD$154.10. Telehealth Booms During Pandemic With […]
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Undergoes Minor Volatility Following New Licensing Deals
Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock prices were down by a concerning 5.53% as of the market closing, bringing the price per share down to USD$2.05 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 1.46%, bringing it up to USD$2.08. New Licensing Deals June 1st, 2021 saw […]
SCWorx Corp. (WORX) Stock on the Rise Following Regaining of Nasdaq Compliance
SCWorx Corp. (WORX) stock prices were up by 2.61% as of the market closing on June 1st, 2021, bringing the price per share up to USD$1.57 at the end of the trading day. Subsequent pre-market fluctuations saw the stock rise by a significant 15.92%, bringing it up to USD$1.82. Regaining Nasdaq Compliance The company announced […]
iRhythm Technologies Inc. (IRTC) Stock Dips Following Leadership Transition
iRhythm Technologies Inc. (IRTC) stock prices were up by 1.05% as of the market closing on June 1st, 2021, bringing the price per share up to USD$76.25 at the end of the trading day. Pre-market fluctuations saw the stock fall by a sharp 13.31%, bringing it down to USD$66.10. 510k Clearances May 24th, 2021 saw […]
Akebia Therapeutics, Inc. (AKBA) Stock On the Rise Following Progression of Vadadastut’s Commercial Development
Akebia Therapeutics, Inc. (AKBA) stock prices were up by a marginal 0.29% as of the market closing on May 28th, 2021, bringing the price per share up to USD$3.51 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 9.97%, bringing it up to USD$3.86. NDA Submission […]
Berkeley Lights, Inc. (BLI) Stock Undergoes Minor Volatility as Development of Opto Assure Continues
Berkeley Lights, Inc. (BLI) stock prices were down by 3.18% as of the market closing on May 28th, 2021, bringing the price per share down to USD$43.50 at the end of the trading day. Revenue Reports and Growth in Bases The leader in Digital Cell Biology reported having generated USD$18.6 million in total revenue over […]
Liminal BioSciences Inc. (LMNL) Stock on the Rise Following Collaborative Agreements with Kedrion
Liminal BioSciences Inc. (LMNL) stock prices were up 4.49% as of the market close on May 28th, 2021, bringing the price per share up to USD$4.42 at the end of the trading day. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Divestment of Plasma Centers The […]
Mannatech, Inc. (MTEX) Stock on the Rise Following Disclosure of Promising Q1 2021 Financial Reports
Mannatech, Inc. (MTEX) stock prices were up by a significant 21.32% shortly after the market trading commenced on May 28th, 2021, bringing the price per share up to USD$24.87 early in the trading day. Net Sales The company reported net sales for the first quarter of the fiscal year 2021 n the amount of USD$38.3 […]
AIM ImmunoTech Inc. (AIM) Stock Undergoes Minor Volatility After Announcing Extension of Collaboration with Smoore
AIM ImmunoTech Inc. (AIM) stock prices were down by 1.42% as of the market closing on May 28th, 2021, bringing the price per share down to USD$2.08 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock fall by 2.40%, bringing it down to USD$2.03. Extension of Agreement with Smoore May […]
Syros Pharmaceuticals, Inc. (SYRS) Stock on the Rise following Promising Financial Reports for Q1 2021
Syros Pharmaceuticals, Inc. (SYRS) stock prices were up by 17.98% shortly after market trading commenced, bringing the price per share up to USD$6.60 early in the trading day. Revenue Breakdown Revenues for the first quarter of the fiscal year 2021 were reported at USD$4.8 million of which USD$4 million in revenue being recognized under the […]
Purple Biotech Ltd. (PPBT) Stock Undergoes Minor Volatility Amid Progression of CM24 Clinical Trial
Purple Biotech Ltd. (PPBT) stock prices were up by 2.15% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.76 at the end of the trading day. Subsequent pre-market fluctuations saw the price dip by a marginal 1.05%, bringing it down to USD$4.71. CM24 Trial Commences Patient Dosing […]
Tenax Therapeutics, Inc. (TENX) Stock Undergo Minor Volatility Following Further Development of its Pipeline Candidates
Tenax Therapeutics, Inc. (TENX) stock prices were down by a marginal 0.53% as of the market closing on May 25th, 2021, bringing the price per share down to USD$1.88 at the end of the trading day. R&D Expenses Expenses incurred by research and development during the first quarter of the fiscal year 2021 came out […]
Owens & Minor, Inc. (OMI) Stock on the Rise Following Outlining of Long-Term Strategy to Drive Sustainable Growth
Owens & Minor, Inc. (OMI) stock prices were up by 23.45% early in the trading day, bringing the price per share up to USD$40.06 shortly after the commencing of market trading. Stellar Guidance Reports With the company finding itself in the fortuitous circumstance of being in a stronger position than it was before the onset […]
Taiwan Liposome Company, Ltd. (TLC) Stock Soars After Indian Approval for AmphoTLC
Taiwan Liposome Company, Ltd. (TLC) stock prices were up by 34.95% shortly after the market opened on May 25th, 2021, bringing the price per share up to USD$6.68 shortly after the trading day commenced. Indian Approval for AmphoTLC TLC announced on May 25th, 2021 that the Central Drugs Standard Control Organization (CDSCO) of India had […]
ThermoGenesis Holdings, Inc. (THMO) Stock Continues Trending Up With Easing of Pandemic Restrictions
ThermoGenesis Holdings, Inc. (THMO) stock prices were up by 5.83% as of the market closing on May 24th, 2021, bringing the price per share up to USD$2.54 at the end of the trading day. PXP-LAVARE Progress The company announced early in February of 2021 that it had finished the process of developing its innovative PXP-LAVARE […]
Hoth Therapeutics, Inc. (HOTH) Stock Poised to Surge Pending Orphan Drug Designation Approval
Hoth Therapeutics, Inc. (HOTH) stock prices were up by 6.43% as of the market closing on May 21st, 2021, bringing the price per share up to USD$1.49 at the end of the trading day. Subsequent pre-market fluctuations saw the price fall by a marginal 2.68%, bringing it down to USD$1.45. HT-KIT HOTH announced early in […]
Myovant Sciences Ltd. (MYOV) Stock Continues Uptrend Following Pipeline Candidate Development
Myovant Sciences Ltd. (MYOV) stock prices were up by 3.33% as of the market closing on May 21st, 2021, bringing the price per share up to USD$22.98 at the end of the trading day. Launch of ORGVYX ORGOVYX saw its launch in the United States commencing in early January of the fiscal year 2021, with […]
Butterfly Network, Inc. (BFLY) Stock Undergoes Minor Volatility Following Promising Q1 2021 Financial Reports
Butterfly Network, Inc. (BFLY) stock prices were down by a marginal 0.20% as of the market closing on May 21st, 2021, bringing the price per share down to USD$10.16. Revenue Breakdown May 13th, 2021 saw the company disclose their financial results for the first quarter of the fiscal year 2021. Revenues were reported to have […]
Annovis Bio, Inc. (ANVS) Stock Skyrockets Following Success of Clinical Trial and Subsequent Public Offering
Annovis Bio, Inc. (ANVS) stock prices skyrocketed by a staggering 127.27% as of the market closing on May 21st, 2021, bringing the price per share up to an even USD$60.00. ANVS401 Study The company announced on May 21st, 2021 the success of its double-blind placebo-controlled study in the treatment of Alzheimer’s Disease. Patients treated with […]
Jiuzi Holdings, Inc. (JZXN) Stock Surges Shortly After its Initial Public Offering Closes
Jiuzi Holdings, Inc. (JZXN) stock prices were up by a promising 23.85% as of the market opening on May 21st, 2021, bringing the price per share up to $0.19 shortly after the trading day commenced. Closing of IPO The company announced on May 20th, 2021 the closing of its initial public offering (IPO) of common […]
Onconova Therapeutics, Inc. (ONTX) Stock Skyrockets Following Reverse Stock Split
Onconova Therapeutics, Inc. (ONTX) stock prices were down by a substantial 21.08% as of the market closing on May 20th, 2021, bringing the price per share down to USD$0.73 at the end of the trading day. Subsequent pre-market fluctuations saw the price skyrocket by a monumental 1235.62%, bringing the price per share up to USD$9.69. […]
Intec Pharma Ltd. (NTEC) Stock Trending Higher Following Progress on Merger with Decoy Biosystem
Intec Pharma Ltd. (NTEC) stock prices were up by 3.02% as of the market closing on May 20th, 2021, bringing the price per share up to USD$3.75 at the end of the trading day. Merger with Decoy Announced March 15th, 2021 saw NTEC announce that it had entered into a definitive agreement with Decoy Biosystems. […]
PolarityTE, Inc. (PTE) Stock Trending Down Shortly After Disclosure of Promising Q1 2021 Financials
PolarityTE, Inc. (PTE) stock prices were down by 6.62% as of the market closing on May 17th, 2021, bringing the price per share down to USD$0.912 at the end of the trading day. Promising Trajectory The company consolidated its prior guidance in the first quarter of the fiscal year 2021 in regard to the submission […]
Oragenics, Inc. (OGEN) Stock Undergoes Volatility Following Changes in Management and Board of Directors
Oragenics, Inc. (OGEN) stock prices were up by 3.32% as of the market closing on April 14th, 2021, bringing the price per share up to USD$0.6199 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock jump by 1.64%, bringing it up to USD$0.62. Net Loss Reports March 3rd, 2021 saw […]
Alterity Therapeutics Ltd. (ATHE) Stock Prices on the Rise Following Promising Progress of ATH434 Development
Alterity Therapeutics Ltd. (ATHE) stock prices were up by 8.77% as of the market closing on May 14th, 2021, bringing the price per share up to USD$1.24. Solid Liquidity Position In an update on company activities for the quarter ending 31st March 2021, ATHE announced a solid liquidity position of USD$32.8 million. Along with operational […]
Checkpoint Therapeutics, Inc. (CKPT) Stock Undergoes Volatility after Release of Q1 2021 Financial Reports
Checkpoint Therapeutics, Inc. (CKPT) stock prices were up 4.17% as of the market closing on May 11th, 2021, bringing the price per share up to USD$2.50. Subsequent pre-market fluctuations have seen the stock fall 9.20%, down to USD$2.27. Cosibelimab Development The company recently reported the continued advancement of the development of CKPT’s two lead drug […]
Precipio, Inc. (PRPO) Stock On the Rise Following Launch of AML HemeScreen Panel
Precipio, Inc. (PRPO) stock prices were up by 15.63% as of the market closing on May 10th 2021, bringing the price per share surging to USD4.44. Subsequent pre-market fluctuations saw the stock further climb by 4.05% to hit USD$4.62. Launch of AML HemeScreen Panel PRPO recently announced the launch of its new Acute Myeloid Leukemia […]
Obalon Therapeutics, Inc. (OBLN) Stock Skyrockets after Class-Action Lawsuit Controversy Dies Down
Obalon Therapeutics, Inc. (OBLN) stock prices skyrocketed by 30.45% as of the market closing on May 10th, 2021, bringing the price per share up to USD$2.87 at the end of the trading day. OBLN’s Merger with ReShape November 10th, 2020 saw the pioneer of the FDA-approved balloon system for obesity treatment announce that it had […]
Conformis, Inc. (CFMS) Stock Trending Up Following 510(k) Clearance from FDA for Identity Imprint
Conformis, Inc. (CFMS) stock prices were up 5.9061% during the first half of the trading day on May 10th, 2021, bringing the price per share up to USD$0.8912. 510(k) Clearance for Conformis May 10th, 2021 saw CFMS announce that the U.S. Food and Drug Administration had granted 510(k) clearance to the company’s Identity Imprint Knee […]
BioLineRx Ltd. (BLRX) Stock Floats Back Down After Skyrocketing from Success of GENESIS Trial
BioLineRx Ltd. (BLRX) stock prices were down by 3.38% as of the market closing on May 7th, 2021, bringing the price per share down to USD$3.72. Subsequent pre-market fluctuations saw the price fall by another 4.30%, bringing it to USD$3.56. Phase 3 GENESIS Trial The achieving of top-line results by BLRX for their GENESIS Phase […]
Ra Medical Systems, Inc. (RMED) Stock Trending Up as DABRA Atherectomy Trial Gains Traction
Ra Medical Systems, Inc. (RMED) stock prices were up by 9.26% as of market close on May 7th 2021, bringing the price per share up to USD$4.13 at the end of the trading day. DABRA Enrollment Progress RMED recently announced an increase in enrolment for its pivotal clinical trial for DABRA, with a total of […]
Regional Health Properties, Inc. (RHE) Stock Skyrockets Following Trading of Exponential Volume of Shares
Regional Health Properties, Inc. (RHE) stock prices soared by 31.4% during early market hours on May 7th 2021, bringing the price per share up to USD$19.68 for a strong start to the trading day. Rent Collection Report Improvement RHE reported as of December 31st 2020 that it had successfully collected 80% of contractual cash that […]
Epizyme, Inc. (EPZM) Stock Experiences Volatility Following Disclosure of Q1 2021 Financial Reports
Epizyme, Inc. (EPZM) stock prices were down by 9.44% as of the market closing on May 6th 2021, bringing the price per share down to USD$6.81 at the end of the trading day. Subsequent current-market fluctuations have seen the stock rally by 20%, bringing it up to USD$8.17. Financial Reports Indicate Strong Growth The first […]
Stealth BioTherapeutics Corp (MITO) Stock Going Down in PreMarket, Here’s What You Should Know
Stealth BioTherapeutics Corp (MITO) stock prices were up by a colossal 35% as of the market closing on May 6th, 2021, bringing the price per share up to USD$1.62. Subsequent pre-market fluctuations saw the price fall by 11.11%, bringing it down to USD$1.44. Collaboration with DCN The company reported having convened with the Division of […]
Obalon Therapeutics, Inc. (OBLN) Stock Undergoes Volatility as Pandemic Regulations Relaxed
Obalon Therapeutics, Inc. (OBLN) stock prices were down by 15.13% as of the market closing on May 6th, 2021, bringing the price per share down to USD$2.02. Subsequent pre-market fluctuations have seen the stock rally by 9.90%, bringing it up to UD$2.22. Merger with ReShape Lifesciences The pioneer of the FDA-approved balloon system of treatment […]
Precipio, Inc. (PRPO) Stock Trending Up Following Successful Launch of Covid-19 Antibody Testing Kit
Precipio, Inc. (PRPO) stock prices were down 3.62% as of the market closing on ay 5th 2021, bringing the price per hare down to UD$5.06 at the end of the trading day. Subsequent pre-market fluctuations have seen the price go up by 7.51%, bringing it up to USD$5.44. Launch of Covid-19 Antibody Testing Kit May […]
American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded
American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up to USD$3.55. Subsequent pre-market fluctuations saw the stock further soar by 30.01%, bringing it up to USD$4.57. Revenues for Q4 2020 In the company’s most recently disclosed financial reports, AMS reported […]
Vapotherm, Inc. (VAPO) Stock Poised to Recover Following Reports of Promising Q1 2021 Financials
Vapotherm, Inc. (VAPO) stock prices were down by a marginal 1.14% as of the market closing on May 5th, 2021, bringing the price per share down to USD$21.63. Massive Increases in Revenue The first quarter of the fiscal year 2021 reported USD32.3 million in net revenue, representing a 69% increase from the same quarter of […]
Regional Health Properties, Inc. (RHE) Stock Skyrocketing as Pandemic Regulations Ease Up
Regional Health Properties, Inc. (RHE) stock prices were up a staggering 90.39% during the course of the trading day on May 5th, 2021, bringing the price per share up to USD$18.91. Promising Rent Collection Reports As of December 31st, 2020, RHE had collected 80% of contractual cash due for the fourth quarter of 2020 and […]
Clovis Oncology, Inc. (CLVS) Stock Trending Up Following Disclosure of Promising Q1 2021 Financial Reports
Clovis Oncology, Inc. (CLVS) stock prices were up a promising 8.89% shortly after the trading day commenced on May 5th, 2021, bringing the price per share up to USD$6.00. Comparative Decrease in Revenue CLVS reported USD$38.1 million in global net product revenues derived from the company’s flagship Rubraca in the first quarter of the fiscal […]
BioLineRX Ltd (BLRX) Stock Skyrockets Following Immense Success of Phase 3 GENESIS Clinical Trial
BioLineRx Ltd. (BLRX) stock prices skyrocketed by 52.98% as of market close on May 3rd 2021, bringing the price per share up to USD$4.88 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock surge another 16.6% to hit USD$5.69. Phase 3 GENESIS trial BLRX announced on May 4th, 2021 the […]
Cocrystal Pharma, Inc. (COCP) Stock Skyrocketed Following Promising Updates on Covid-19 Drug Development
Cocrystal Pharma, Inc. (COCP) stock prices were up by a monumental 72.58% as of the market closing on may 4th 2021, bringing the price per share up to USD$2.14 at the end of the trading day. Subsequent pre-market fluctuations saw the stock fall by a significant 22.9%, bringing it down to USD$1.65. Covid-19 Treatment Program […]
Savara Inc. (SVRA) Stock Trending Down as Phase 3 of IMPALA 2 Trial Expected to Commence Soon
Savara Inc. (SVRA) stock prices were down by 3.95% as of the market closing on May 4th 2021, bringing the price per share down to USD$1.70 at the end of the trading day. 11th Hour Failure SVRA announced near the end of 2020 that the Phase 3 trial of AeroVanc did not meet its primary […]
Amgen, Inc. (AMGN) Stock Prices Undergo Volatility as Global Pandemic on Verge of Easing Up
Amgen, Inc. (AMGN) stock prices were down a marginal 0.15% as of market close on April 27th, 2021, inching the price down to USD$255.13. Subsequent pre-market fluctuations saw the stock price fall by 3.38%, bringing the price per share down to USD$246.50. Total Revenues Suffer The COVID-19 pandemic has been devastating for Amgen since its […]
Cassava Sciences, Inc. (SAVA) Stock Prices on the Rise After Success of Clinical Trials
Cassava Sciences, Inc. (SAVA) stock prices were up 5.61% as of market close on April 26th 2021, bringing the price per share up to USD$41.81 at the end of the trading day. Subsequent current market fluctuations saw the stock price climb 3.78% to it USD$43.39. SAVA’s Net Loss In their recently disclosed financial reports for […]
Aldeyra Therapeutics, Inc. (ALDX) Stock Prices Surge After News of Clinical Trial Success
Aldeyra Therapeutics, Inc. (ALDX) stock prices were up 4.81% as of market close on April 26th, 2021 bringing the price per share up to USD$11.11. Subsequent pre-market fluctuations have seen the stock price surge by 21.78%, bringing it up to USD$13.53. Success of INVIGORATE Clinical Trial The sharp increase in ALDX stock prices came hot […]
Teligent, Inc. (TLGT) Stock Prices Trend Up as Company Consolidates its Financials and Hires New Senior Management
Teligent, Inc. (TLGT) stock prices were up 3.69% as of market close on April 26th, 2021, bringing the price per share up to USD$0.6010. Subsequent pre-market fluctuations saw the stock surge 12.31%, bumping it up to USD$0.68. Conversion of Outstanding Debt January 27th, 2021 saw the company’s Series C noteholders exchange the entirety of their […]